ES2037808T3 - Procedimiento para la obtencion de medicamentos para la profilaxis y terapia de enfermedades producidas por retrovirus. - Google Patents

Procedimiento para la obtencion de medicamentos para la profilaxis y terapia de enfermedades producidas por retrovirus.

Info

Publication number
ES2037808T3
ES2037808T3 ES198888120960T ES88120960T ES2037808T3 ES 2037808 T3 ES2037808 T3 ES 2037808T3 ES 198888120960 T ES198888120960 T ES 198888120960T ES 88120960 T ES88120960 T ES 88120960T ES 2037808 T3 ES2037808 T3 ES 2037808T3
Authority
ES
Spain
Prior art keywords
retroviruses
prophylaxis
therapy
procedure
diseases produced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888120960T
Other languages
English (en)
Inventor
Dieter Dr. Herr
Thomas Dr. Doerper
Lothar Dr. Daum
Karl-Heinz Dr. Geiss
Achim Dr. Moeller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Application granted granted Critical
Publication of ES2037808T3 publication Critical patent/ES2037808T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Abstract

SE DESCRIBE LA UTILIZACION DE HEPALINA POLISULFATADA PARA LA OBTENCION DE MEDICAMENTOS PARA LA TERAPIA Y PROFILAXIS DE ENFERMEDADES CAUSADAS POR RETROVIRUS.
ES198888120960T 1987-12-24 1988-12-15 Procedimiento para la obtencion de medicamentos para la profilaxis y terapia de enfermedades producidas por retrovirus. Expired - Lifetime ES2037808T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873744119 DE3744119A1 (de) 1987-12-24 1987-12-24 Verwendung von polysulfatierten heparinen

Publications (1)

Publication Number Publication Date
ES2037808T3 true ES2037808T3 (es) 1993-07-01

Family

ID=6343619

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888120960T Expired - Lifetime ES2037808T3 (es) 1987-12-24 1988-12-15 Procedimiento para la obtencion de medicamentos para la profilaxis y terapia de enfermedades producidas por retrovirus.

Country Status (8)

Country Link
US (1) US4966894A (es)
EP (1) EP0322659B1 (es)
JP (1) JPH01230519A (es)
AT (1) ATE69953T1 (es)
AU (1) AU608677B2 (es)
DE (2) DE3744119A1 (es)
ES (1) ES2037808T3 (es)
ZA (1) ZA889699B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272261A (en) * 1989-01-11 1993-12-21 Merrell Dow Pharmaceuticals Inc. Preparation of sulfated polysaccharide fractions
CA2026990C (en) * 1989-02-10 1996-06-25 Hiroo Hoshino Anti-hiv agent
DE3928769A1 (de) * 1989-08-31 1991-03-14 Ulrich Dr Med Kuebler Verfahren und pharmazeutische mischung zur aufrechterhaltung und wiederherstellung des zinkgehaltes von retroviral infizierten zellen, sowie zur unterdrueckung und prophylaxe der transformierung von humanen b-lymphozyten durch eb-viren
IT1237518B (it) * 1989-11-24 1993-06-08 Renato Conti Eparine supersolfatate
US5141928B1 (en) * 1989-12-20 1995-11-14 Brujo Inc Ophthalmic medication
DE4021066A1 (de) * 1990-07-03 1992-01-09 Hoechst Ag Langzeitprophylaxe gegen erkrankungen, die durch viren oder durch unkonventionelle viren verursacht werden
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
US5670144A (en) * 1990-07-09 1997-09-23 Merrell Pharmaceuticals Inc. Anti-herpes virus and cytomegalovirus polyester oligomers
SE9101155D0 (sv) * 1991-04-18 1991-04-18 Kabi Pharmacia Ab Novel heparin derivatives
US5424063A (en) * 1992-01-09 1995-06-13 The Dow Chemical Company Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process
US5514665A (en) * 1993-12-30 1996-05-07 University Of British Columbia Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
IL112174A (en) * 1994-01-03 1999-05-09 Merrell Dow Pharma Oligomers of polythioureas pharmaceutical compositions containing them and a process for their preparation
DE29900874U1 (de) * 1999-01-20 1999-07-22 Knoll Ag Organprotektive Lösungen
AU2003290714A1 (en) * 2003-11-06 2004-06-06 Becton, Dickinson And Company Novel methods for administration of drugs and devices useful thereof
AR043110A1 (es) * 2004-02-04 2005-07-20 Syntex Sa Sal de heparina de bajo peso molecular con trietanolamina util como agente terapeutico-antitrombotico de administracion topica, procedimientos para preparar dichas sales, proceso para la eliminacion de la higroscopicidad de la sal de heparina, composiciones farmaceuticas para uso topico en terapia a
CN101597343B (zh) * 2009-05-07 2011-06-15 张丽萍 一种低分子肝素的基团修饰方法
US11116819B2 (en) 2013-02-28 2021-09-14 President And Fellows Of Harvard College Methods and compositions for mobilizing stem cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2538404B1 (es) * 1982-12-28 1985-08-23 Anic Spa
CA1218986A (en) * 1982-12-28 1987-03-10 Annamaria Naggi Process for the depolymerisation and sulfatation of polysaccharides
DE3601136A1 (de) * 1986-01-16 1987-07-23 Max Planck Gesellschaft Hemmstoffe der reversen transkriptase fuer prophylaxe und therapie von retrovirus-infektionen in saeugetieren
EP0240098A3 (en) * 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo and polysaccharides for the treatment of diseases caused by retroviruses
NZ222695A (en) * 1986-11-29 1990-03-27 Ueno Seiyaku Oyo Kenkyujo Kk Synergistic antiviral compositions

Also Published As

Publication number Publication date
ZA889699B (en) 1990-08-29
AU608677B2 (en) 1991-04-11
ATE69953T1 (de) 1991-12-15
AU2749288A (en) 1989-06-29
EP0322659A1 (de) 1989-07-05
DE3866686D1 (de) 1992-01-16
JPH01230519A (ja) 1989-09-14
EP0322659B1 (de) 1991-12-04
US4966894A (en) 1990-10-30
DE3744119A1 (de) 1989-07-06

Similar Documents

Publication Publication Date Title
ES2037808T3 (es) Procedimiento para la obtencion de medicamentos para la profilaxis y terapia de enfermedades producidas por retrovirus.
ES2133138T3 (es) Nucleosidos terapeuticos.
FI863703A (fi) Glykocidderivat.
ES2061307T3 (es) Empleo del principio activo azelastina y eteres de glicerol para combatir enfermedades psoriasicas.
ES2034035T3 (es) Procedimiento de preparacion de una forma farmaceutica para la administracion y/o dosificacion de medicamentos.
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
ES2052647T3 (es) Procedimiento para la produccion de un preparado combinado farmaceutico.
EP0417003A3 (en) Use of antiprogestomimetics for stimulating ovulation
IT1095103B (it) Apparecchio medicale per la cura della tromeosi venale profonda
IT8820116A0 (it) Il trattamento delle malattie della procedimento per la preparazione di pelle. una composizione farmaceutica per
ES2081279T3 (es) Utilizacion de 15-desoxiespergualina como medicamento.
DK325387A (da) 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid samt dets fremstilling og anvendelse
ES2059615T3 (es) Empleo del derivado de tiazol tiprotimoda para la preparacion de un agente para la terapia de infecciones por virus.
ES2060440T3 (es) Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos.
DE69033252T2 (de) Therapeutische nukleoside
ES2061718T3 (es) Utilizacion de antigestagenos para la preparacion de medicamentos.
MX9204010A (es) Composicion farmaceutica que contiene 3(3-piridil)-1h,3-pirrol[1,2- c]tiazol-7-carboxamida y procedimiento para su preparacion.
ES2039516T3 (es) Empleo de los enantiomeros de la propafenona para la obtencion de medicamentos.
SE8201308D0 (sv) Alkylendiaminderivat och forfarande for framstellning derav
IT1102304B (it) Composizione farmaceutica per la cura della sordita' e del ronzio auricolare
IT8741690A0 (it) Farmaco per la profilassi e per la cura delle disbatteriosi vaginali.
BR7908996A (pt) Composicao farmaceutica,processo de preparacao de compostos farmaceuticos,processo de prevencao e/ou tratamento de doencas,compostos farmaceutico e processo de prevencao e/ou tratamento de hipocolesterolemia
IT7945204A0 (it) Composizione farmaceutica per la terapia delle sterilita' maschile
IT8519776A0 (it) Preparato per la cura esterna delle emorroidi.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 322659

Country of ref document: ES